Boston, MA 06/06/2013 (wallstreetpr) – The share prices of Atossa Genetics Inc. (NASDAQ:ATOS) had surged by 13.46 percent to close at $4.89 per share for the end of last trading session on Wednesday. The shares of the company had been trading in the range of $4.11 to $5.05 during the day. The shares of Atossa Genetics Inc. (NASDAQ:ATOS) had recorded 52 week low price level of $3.44 per share and 52 week high price level of $12.40 per share.
Atossa Genetics Inc. (NASDAQ:ATOS) is a healthcare company in the development stage with its primary focus on prevention of breast cancer. The company thereby works on development and commercialization of diagnostic tests to detect precursors to breast cancer. Atossa Genetics Inc. (NASDAQ:ATOS) also works seriously on the research and development of treatments for pre – cancerous lesions.
Atossa Genetics Inc. (NASDAQ:ATOS) had announced that Peter J. Carbonaro had joined the health care company as Senior Vice President of Operations. This is a newly created post in the company which would have primary focus and responsibilities related to regulatory, quality, IT, manufacturing, human capital and supply chain requirements.
The shares of Atossa Genetics Inc. (NASDAQ:ATOS) had recently been trading at positive gains with surge in trading volumes. The company witnessed the trade of 257,574 shares on Wednesday, while the average trading volume of Atossa Genetics Inc. (NASDAQ:ATOS) is at 164,530 shares per day.
Atossa Genetics Inc. (NASDAQ:ATOS) presently holds 12.92 million shares outstanding in the market with a market capitalization of $63.18 million.
